Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 2772 of 5804
-
Could a ketone drink curb binge and restrict urges?
Symptom relief OngoingThis study will investigate the effects of ketone supplementation on eating behavior including drive to binge eat or restrict, mood and anxiety in individuals with anorexia or bulimia nervosa. In addition, the investigators will contrast the effects of active ketone supplementati…
Phase: NA • Sponsor: University of California, San Diego • Aim: Symptom relief
Last updated Jun 26, 2026 12:58 UTC
-
Gene test could take the guesswork out of Post-Surgery pain relief
Symptom relief CompletedPharmacogenomics (PGx) is the study of how genes affect a person's response to drugs. PGx testing for certain genes can help predict the risk of side effects or therapeutic failure from analgesics. Testing is not regularly performed in clinical practice due to long wait times for…
Phase: NA • Sponsor: University of Pennsylvania • Aim: Symptom relief
Last updated Jun 27, 2026 12:02 UTC
-
Can facial exercises ease the stiffness of scleroderma?
Symptom relief Recruiting nowSystemic sclerosis is a rare autoimmune disorder characterized by microangiopathy, activation of the immune system, and sclerosis of tissues including the skin. Facial involvement is frequent and disabling. It causes significant functional and aesthetic discomfort, and a major de…
Phase: NA • Sponsor: University Hospital, Strasbourg, France • Aim: Symptom relief
Last updated Jun 27, 2026 13:04 UTC
-
Mind over diabetes: new program aims to get patients moving
Symptom relief Recruiting nowThe focus of this study is to test the efficacy of an 8-week, remotely delivered, positive-psychology-motivational interviewing (PP-MI) intervention, with additional twice weekly text messages for a total of 16 weeks (with interactive, algorithm-driven, goal-focused text messages…
Phase: NA • Sponsor: Massachusetts General Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 12:06 UTC
-
Hospital checklist aims to curb HIV in drug users
Prevention CompletedThe purpose of this study is to develop and test a serious injection-related injections (SIRI) checklist aimed at increasing evidence-based treatment for rural people who use drugs (PWUD) including innovative, long-acting injectable agents. The central hypothesis is that hospital…
Phase: NA • Sponsor: University of Alabama at Birmingham • Aim: Prevention
Last updated Jun 27, 2026 09:06 UTC
-
New therapy aims to ease grief and PTSD for families of ICU patients
Symptom relief Recruiting nowHypotheses 1a and 1b: Compared to Supportive Conversation arm, the EMPOWER intervention will significantly decrease surrogate decision makers' symptoms of grief and Post Traumatic Stress Disorder (PTSD) (primary outcomes); and H1b. experiential avoidance, depression, regrets, and…
Phase: PHASE2 • Sponsor: Weill Medical College of Cornell University • Aim: Symptom relief
Last updated Jun 27, 2026 07:56 UTC
-
Parent coaching shows promise for Kids' mental health
Symptom relief Recruiting nowEmotion Focused Family Therapy (EFFT) is a promising intervention that aims to teach parents advanced skills to support their child's development of emotion skills and increase their adaptive behaviours, potentially leading to improvements in their child's psychological functioni…
Phase: NA • Sponsor: University of Guelph • Aim: Symptom relief
Last updated Jun 27, 2026 08:13 UTC
-
AI-Powered symptom watch aims to keep head and neck cancer patients out of the ER
Symptom relief OngoingThis clinical trial compares intensive symptom evaluation with supportive care to standard symptom management in patients with head and neck cancer that has not spread to other places in the body (non-metastatic). Standard symptom management involves symptom management during and…
Phase: NA • Sponsor: Roswell Park Cancer Institute • Aim: Symptom relief
Last updated Jun 27, 2026 08:13 UTC
-
New drug cocktail targets rare eye cancer
Disease control OngoingThis is a prospective phase II multi-center trial of the combination of the PARP inhibitor olaparib with the immune checkpoint inhibitor pembrolizumab in advanced uveal melanoma.
Phase: PHASE2 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Cord stem cells inhaled for lung scarring: first human test
Disease control CompletedMain purpose -To explore the safety and tolerance of human umbilical cord mesenchymal stem cells in the treatment of idiopathic pulmonary fibrosis (IPF). Secondary purpose * To explore the preliminary efficacy of human umbilical cord mesenchymal stem cells in the treatment of …
Phase: PHASE1 • Sponsor: Shanghai Life Science & Technology • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
New drug JZP815 targets tough cancers in early trial
Disease control Recruiting nowThis phase 1 study will investigate the safety, dosing, and initial antitumor activity of JZP815 in participants with advanced or metastatic solid tumors harboring alterations in the MAPK pathway.
Phase: PHASE1 • Sponsor: Jazz Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New pill plus chemo shows early promise in tough pancreatic cancer
Disease control CompletedThe objective of study IOA-289-102 is to evaluate the safety and tolerability of escalating doses of IOA-289 in patients with metastatic pancreatic cancer in combination with standard chemotherapy consisting of gemcitabine and nab-paclitaxel. Blood and tumour samples for PK and P…
Phase: PHASE1, PHASE2 • Sponsor: iOnctura • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
Breast cancer study seeks to match drug to tumor patterns
Knowledge-focused Recruiting nowThe purpose of this observational study is to learn about the HER2 heterogeneity and its impact on benefit from trastuzumab deruxtecan in metastatic breast cancer. The main question it aims to answer is: \- Does the heterogeneity of HER2 expression level and spatial distribution…
Sponsor: Sun Yat-sen University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:37 UTC
-
Can learning to see Others' perspectives help depressed teens?
Symptom relief Recruiting nowDepression in youth is a serious public health concern for which more personalized treatments are needed. This randomized controlled trial will test the effect of an intervention aimed at enhancing social cognitive capacities (e.g., ability to take another's perspective), thereby…
Phase: NA • Sponsor: Vanderbilt University • Aim: Symptom relief
Last updated Jun 26, 2026 14:37 UTC
-
New combo therapy targets tough lung cancer in early trial
Disease control OngoingThis study aims to determine the safety, preliminary antitumor activity, and pharmacokinetics (PK) of RYZ101 in combination with standard of care (SoC) therapy consisting of carboplatin + etoposide + atezolizumab in untreated subjects with somatostatin receptor expressing (SSTR+)…
Phase: PHASE1 • Sponsor: RayzeBio, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
New hope for advanced breast cancer: early trial of oral drug LY3484356 begins
Disease control OngoingThis is a study of LY3484356 in Chinese participants with advanced breast cancer. Participants must have breast cancer that is estrogen receptor positive (ER+), HER2 negative (HER2-). The purpose of this study is to measure how much LY3484356 gets into the bloodstream and how lon…
Phase: PHASE1 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
Warm compresses vs. High-Tech eye gadgets: which best treats dry eye?
Symptom relief CompletedMeibomian gland dysfunction (MGD), closely associated with Dry Eye Disease (DED), is a chronic condition where terminal ducts are obstructed and/or glandular secretion changes. The efficacy of traditional treatment options, e.g. eyelid warm compress therapy (EW) is limited with l…
Phase: NA • Sponsor: Chinese University of Hong Kong • Aim: Symptom relief
Last updated Jun 27, 2026 11:03 UTC
-
Can the flu vaccine protect kids with cancer? new study investigates
Knowledge-focused Recruiting nowInfluenza infection occurring during oncologic treatment or following hematopoietic cell transplantation (HCT) is associated with increased risk of morbidity in the form of lower respiratory tract infection (LRTI) and mortality relative to otherwise healthy patients. The study pa…
Sponsor: St. Jude Children's Research Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:05 UTC
-
Can a skin cream make immunotherapy more effective?
Disease control Recruiting nowThis is a phase I, open label study employing diphencyprone (DPCP) to characterize gene expression changes of various immune cell and tumor markers in cutaneous metastases treated with topical DPCP twice weekly for 12 weeks in combination with PD-1 or PD-L1 immune checkpoint inhi…
Phase: PHASE1 • Sponsor: Nicholas Gulati • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
Can a phone or video chat lift depression in older cancer survivors?
Symptom relief Recruiting nowThe purpose of this study is to find out if a psychotherapy method called behavioral activation (BA) can be successfully delivered by telephone or videoconference (remotely) and can effectively treat depression in Older Adult Cancer Survivors (OACS)
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Symptom relief
Last updated Jun 27, 2026 14:01 UTC